Cargando…
A four-compartment PBPK heart model accounting for cardiac metabolism - model development and application
In the field of cardiac drug efficacy and safety assessment, information on drug concentration in heart tissue is desirable. Because measuring drug concentrations in human cardiac tissue is challenging in healthy volunteers, mathematical models are used to cope with such limitations. With a goal of...
Autores principales: | Tylutki, Zofia, Polak, Sebastian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5209692/ https://www.ncbi.nlm.nih.gov/pubmed/28051093 http://dx.doi.org/10.1038/srep39494 |
Ejemplares similares
-
Physiologically based pharmacokinetic-quantitative systems toxicology and safety (PBPK-QSTS) modeling approach applied to predict the variability of amitriptyline pharmacokinetics and cardiac safety in populations and in individuals
por: Tylutki, Zofia, et al.
Publicado: (2018) -
Humans Vary, So Cardiac Models Should Account for That Too!
por: Wiśniowska, Barbara, et al.
Publicado: (2017) -
Top-down, Bottom-up and Middle-out Strategies for Drug Cardiac Safety Assessment via Modeling and Simulations
por: Tylutki, Zofia, et al.
Publicado: (2016) -
Drug-drug interactions and QT prolongation as a commonly assessed cardiac effect - comprehensive overview of clinical trials
por: Wiśniowska, Barbara, et al.
Publicado: (2016) -
Development and Performance Verification of the PBPK Model for Antazoline and Its Metabolite and Its Utilization for Pharmacological Hypotheses Formulating
por: Wiśniowska, Barbara, et al.
Publicado: (2022)